RedHill Biopharma Ltd. financial statements
RedHill Biopharma Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2024
| Revenue | USD 8.04M | 20-F |
| Net income | −USD 8.27M | 20-F |
| Cash and equivalents | USD 4.62M | 6-K |
RedHill Biopharma Ltd. financials on 6ix · RedHill Biopharma Ltd. on 6ix